Frequency of Helicobacter Pylori Infection in Patients with Dyspepsia
DOI:
https://doi.org/10.70749/ijbr.v3i5.1154Keywords:
Helicobacter pylori, Dyspepsia, Infection prevalence, Gastrointestinal disordersAbstract
Background: Helicobacter pylori (H. pylori) is a gram-negative bacterium commonly associated with gastrointestinal disorders, including dyspepsia, peptic ulcers, and gastritis. Objective: This study aimed to determine the frequency of H. pylori infection in patients with dyspepsia and explore its relationship with demographic and clinical factors. Methods: A cross-sectional study was conducted at Unit I, Department of Medicine, Benazir Bhutto Hospital, Rawalpindi. A total of 150 dyspeptic patients, aged 20-70 years, were enrolled using non-probability consecutive sampling. Data were collected on demographic and clinical characteristics, including age, gender, BMI, hypertension, diabetes, smoking history, and family history of dyspepsia. Results: The study found a 45% prevalence of Helicobacter pylori infection in dyspeptic patients. The infection was more common in patients aged 40-60 years and those with a BMI ≥ 30 kg/m². The infection rate was significantly higher in patients with peptic ulcer disease (60%), while lower rates were observed in those with gastroesophageal reflux disease (38%) and other causes of dyspepsia (33%). There was no significant difference in H. pylori infection based on the duration of symptoms, with infection rates ranging from 42% to 48% across the 1-12, 13-24, and 25-36-month duration groups. The T-test analysis revealed a significant difference in BMI between H. pylori positive (27.2 ± 4.5 kg/m²) and negative (24.8 ± 3.9 kg/m²) groups (p = 0.002), but no significant differences were found in age (p = 0.08) or symptom duration (p = 0.12). Conclusion: It is concluded that H. pylori infection is prevalent in dyspeptic patients, with significant associations observed with age and BMI. These findings highlight the need for H. pylori screening in dyspeptic patients, particularly those with higher BMI and from lower socioeconomic backgrounds.
Downloads
References
Tanaka I, Ono S, Shimoda Y, Inoue M, Kinowaki S, Tsuda M, et al. Eradication of Helicobacter pylori may improve dyspepsia in the elderly for the long term. BMC Gastroenterol. 2021;21(1):445 https://doi.org/10.1186/s12876-021-02027-6
Azadbakht S, Azadbakht S, Esmaili A, Rahmani P. Comparison of clinical symptoms after Helicobacter pylori eradication in functional dyspepsia patients based on endoscopic view of antral gastropathy. New Microb New Infect. 2020;38:100806. https://doi.org/10.1016/j.nmni.2020.100806
Suvak B, Dulger AC, Suvak O, Aytemiz E, Kemik O. The prevalence of Helicobacter pylori among dyspeptic patients in an earthquake-stricken area. Clinics. 2015;70(1):69-72. https://doi.org/10.6061/clinics/2015(01)12
Naushad VA, Purayil NK, Badi A, Chandra P, Abuzaid HO, Abuhmaira MM, et al. Potential Predictors and Prevalence of Helicobacter pylori Infection Among Adult Patients With Dyspepsia: A Retrospective Study From Qatar. Cureus. 2021;13(7):e16216. https://doi.org/10.7759/cureus.16216
Oraijah AA, Shaqhan MH, Alhebshi FA, Alsuwat RW, Algethami AH, Alsofyani AH, et al. Prevalence of Helicobacter pylori infection among patients with dyspepsia and other gastrointestinal diseases in King Abdulaziz Specialized Hospital in Taif. J Fam Med Prim Care. 2022;11(10):6493-8. https://doi.org/10.4103/jfmpc.jfmpc_1351_22
Oling M, Odongo J, Kituuka O, Galukande M. Prevalence of Helicobacter pylori in dyspeptic patients at a tertiary hospital in a low resource setting. BMC Res Notes. 2015;8(1):256. https://doi.org/10.1186/s13104-015-1184-y
Rafi W, Noor A, Khan HMH, Butt TA, Haq MIU, Bajwa MM. Frequency of Helicobacter pylori infection in patients with functional dyspepsia. PJMHS. 2022;16(5):504-5. https://doi.org/10.53350/pjmhs22165504
Tooba, Awan RH, Nayab S, Awan KH, Awan FM. Frequency of Helicobacter pylori in patients with functional dyspepsia. Professional Md J. 2019;26(8):1261-5 https://doi.org/10.29309/tpmj/2019.26.08.3866
Hamrah MH, Hamrah MS, Hassan Hamrah M, Kanda M, Hamrah AE, Dahi AE, et al. Prevalence of Helicobacter Pylori Infection in Dyspeptic Patients in Andkhoy Afghanistan. Asian Pac J Canc Prevent. 2017;18(11):3123-7.
Valizadeh Toosi, S. M., Yaghobi, M., & Mohammad Pour, R. A. (2021). Prevalence of Helicobacter Pylori Infection in Patients with Dyspepsia in North of Iran. Middle East journal of digestive diseases, 13(3), 230–236. https://doi.org/10.34172/mejdd.2021.230
Esmaeilzadeh A, Goshayeshi L, Bergquist R, Jarahi L, Khooei A, Fazeli A, Mosannen Mozaffari H, Bahari A, Oghazian MB, Hoseini B. Characteristics of gastric precancerous conditions and Helicobacter pylori infection among dyspeptic patients in north-eastern Iran: is endoscopic biopsy and histopathological assessment necessary? BMC Cancer. 2021 Oct 26;21(1):1143. PMID: 34702194; PMCID: PMC8546943. https://doi.org/10.1186/s12885-021-08626-6.
Negovan A, Szőke AR, Mocan S, Bănescu C. Helicobacter pylori-Positive Gastric Biopsies-Association with Clinical Predictors. Life (Basel). 2022 Nov 4;12(11):1789. PMID: 36362946; PMCID: PMC9699335. https://doi.org/10.3390/life12111789.
Eslami O, Najafzadeh MJ, Shafiei M. The Agreement between Endoscopic and Histopathological Findings of Esophageal and Gastroduodenal Lesions and Its Relationship with Endoscopists' Experience. Middle East J Dig Dis. 2023 Oct;15(4):293-296. Epub 2023 Oct 30. PMID: 38523889; PMCID: PMC10955981. https://doi.org/10.34172/mejdd.2023.361.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. https://doi.org/10.3322/caac.21492.
Goshayeshi L, Hoseini B, Yousefli Z, Khooie A, Etminani K, Esmaeilzadeh A, et al. Predictive model for survival in patients with gastric cancer. Electron Physician. 2017;9(12):6035–6042. https://doi.org/10.19082/6035
Javid H, Soltani A, Mohammadi F, Hashemy SI. Emerging roles of microRNAs in regulating the mTOR signaling pathway during tumorigenesis. J Cell Biochem. 2019;120(7):10874–10883. https://doi.org/10.1002/jcb.28401.
Moafian Z, Maghrouni A, Soltani A, Hashemy SI. Cross-talk between non-coding RNAs and PI3K/AKT/mTOR pathway in colorectal cancer. Mol Biol Rep. 2021. https://doi.org/10.1007/s11033-021-06458-y
Lee YC, Chiang TH, Chou CK, Tu YK, Liao WC, Wu MS, et al. Association between helicobacter pylori eradication and gastric cancer incidence: a systematic review and meta-analysis. Gastroenterology. 2016;150(5):1113–24.e5. https://doi.org/10.1053/j.gastro.2016.01.028
Lahner E, Esposito G, Zullo A, Hassan C, Carabotti M, Galli G, et al. Gastric precancerous conditions and helicobacter pylori infection in dyspeptic patients with or without endoscopic lesions. Scand J Gastroenterol. 2016;51(11):1294–1298. https://doi.org/10.1080/00365521.2016.1205129
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research

This work is licensed under a Creative Commons Attribution 4.0 International License.